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The recent identiﬁcation of several novel innate lymphoid cell (iLC) subsets has increased
our understanding of themechanismswhich link the innate and adaptive immune systems.
While the contribution of these subsets toward the pathogenesis of human disease remains
largely to be determined, it seems likely that they will play a particularly important role in
sterile inﬂammatory settings where the innate response is seen as a critical mediator of
inﬂammation. Several recent studies have highlighted the role of endogenous damage-
associated molecular patterns such as IL-33, IL-1α, and IL-1β in promoting lymphoid cell
responses. This review discusses the inﬂuence of such endogenous danger signals on
novel iLCs such as lymphoid tissue-inducer cells, innate type 2 helper cells, and γδT cells
and explores how these responses may contribute to the development of an inﬂammatory
response in a sterile setting.
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INTRODUCTION
Acute inﬂammation directed by the innate immune response has
evolved to efﬁciently combat infection and is critical to host
defense. However, in the absence of overt infection, such innate
mechanismsmay also be activated as a result of tissue injury result-
ing frommetabolic or exogenous sources (Rock et al., 2010). These
events lead to what is termed a sterile inﬂammatory response
which, if not appropriately resolved, can lead to the development
of chronic inﬂammation which underlies or exacerbates a variety
of human diseases.
The driving signals of sterile inﬂammation are known as
damage-associated molecular patterns (DAMPs) and while dis-
tinct from their pathogen-derived counterparts, they elicit their
effects through many of the same signaling pathways and net-
works (Bianchi, 2007). As a result, much of what we know about
the mechanisms involved in sterile inﬂammation has stemmed
from investigations of the innate inﬂammatory response to infec-
tion. Indeed, as a result of collateral damage often observed during
the innate response to infection, DAMPs can also contribute to
inﬂammation in non-sterile settings (Yang and Oppenheim, 2009;
Yang et al., 2009; Andersson and Tracey, 2011). Most studies on the
sterile inﬂammatory response have focused on the sources of these
endogenous DAMPs, such as necrotic cells (Krysko et al., 2011).
However, there is a growing awareness of the inﬂuence DAMPs
play in orchestrating sterile inﬂammation through activating dif-
ferent cell types (Nace et al., 2012). This review will focus on the
effects of speciﬁc DAMP activity on recently deﬁned innate lym-
phoid cell (iLC) populations and how these distinct populations of
cells play a role in orchestrating subsequent inﬂammatory events
relevant to human disease.
DAMAGE-ASSOCIATED MOLECULAR PATTERNS
Damage-associated molecular patterns (DAMPs) are proinﬂam-
matory mediators largely activated under conditions of cellular
stress or injury which may ultimately result in cell death. Stimuli
which elicit these responses can range from sterile particulates
derived from either aberrant metabolism, e.g., cholesterol crys-
tals in atherosclerosis (Duewell et al., 2010) or external toxins, e.g.,
asbestos (Dostert et al., 2008). Similarly, unprogramed cell death,
such as that observed under ischemic conditions or chemother-
apeutic treatment strategies, leads to a loss of cellular integrity
which can result in the exposure of DAMPs and the development
of sterile inﬂammation (Arslan et al., 2011; Awong et al., 2012).
In recent times, the identity of several DAMPs has been revealed
and their effects on the generation of the sterile immune response
described. As this reviewwill focus onhow these signals speciﬁcally
inﬂuence iLCs responses, a number of the most relevant DAMPs
are described below.
IL-1 α/β
The proinﬂammatory effects of both IL-1α and IL-1β have long
been recognized. Although both DAMPs share the same IL-
1 receptor, and thus appear to elicit very similar effects, their
expression and activity are distinctly regulated (Dinarello, 2009).
IL-1β gene expression is induced upon stimulation by numer-
ous inﬂammatory signals but is normally translated in its inactive
proform. Prior to its release from cells IL-1β undergoes matura-
tion through proteolytic cleavage by caspase-1 in events mediated
by an inﬂammasome involving the proteins NLRP3 and ASC (Li
et al., 1995; Lamkanﬁ and Dixit, 2009). Critically, activation of the
signaling events required for the appropriate assembly and acti-
vation of this NLRP3 inﬂammasome are known to be mediated
by a wide range of sterile particulates and metabolites implicat-
ing IL-1β as central to numerous sterile inﬂammatory conditions
(Martinon et al., 2006; Dostert et al., 2008; Masters et al., 2010).
Unlike IL-1β, IL-1α appears to be constitutively expressed by a
wider range of cell types and although it also undergoes prote-
olytic cleavage, is active in its unprocessed form. Although IL-1α
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does not appear to require inﬂammasome activity for its activa-
tion it is known to be released in large amounts upon cell death
through necrosis and has been found play a central role in driv-
ing neutrophil recruitment as part of the sterile inﬂammatory
response (Chen et al., 2007).
The effects of IL-1 activity on both the innate and adaptive
immune responses have been extensively characterized (Dinarello,
2009), and there is accumulating evidence that these DAMPs play
an important role in driving iLC subset responses. These events are
likely to play a signiﬁcant role in driving neutrophil recruitment
under sterile conditions and are discussed in greater detail below.
IL-33
IL-33 is another member of the IL-1 family of cytokines which is
exposed upon cellular injury and acts upon its cognate recep-
tor ST2 in complex with the IL-1RAcP (Schmitz et al., 2005).
Although originally thought to be post transcriptionally regulated
by caspase-1-mediated cleavage, in a manner similar to IL-1β, it
is now apparent that IL-33 exhibits biological activity in its full-
length uncleaved form and is released upon necrotic cell death to
exert its biological activity in a similarmanner to IL-1α (Liew et al.,
2010). As well as acting as a classical “alarmin,” intracellular IL-
33 can also act as a transcriptional repressor although the speciﬁc
genes andpathwayswhich it targets in this role are notwell-deﬁned
(Carriere et al., 2007; Ali et al., 2011). Release of IL-33 is strongly
implicated as an instructive signal in the development of type 2
immune responses and as such it is thought to play an important
role in the allergic response (Schmitz et al., 2005). More recently it
has been demonstrated that IL-33 has profound effects on innate
type 2 helper cells and nuocytes and may play a central role in
driving type 2 immunity under sterile settings (Kim et al., 2012;
Mirchandani et al., 2012). The inﬂuence of IL-33 on iLC popula-
tions in the context of sterile inﬂammation is discussed in further
detail below.
EFFECTS OF DAMPs ON INNATE LYMPHOID CELL SUBSETS
The effects of DAMP signaling on cells of the innate immune
system such as dendritic cells and macrophages have been exten-
sively described elsewhere (Chen and Nunez, 2010). Similarly,
since their earliest identiﬁcation there have been numerous stud-
ies detailing how endogenous DAMPs can directly inﬂuence the
adaptive T cell response. For example, HMGB1, CpG contain-
ing DNA motifs, and hsp60 have all been described to directly
inﬂuence activated T cell responses (Dumitriu et al., 2005; Zanin-
Zhorov et al., 2006; LaRosa et al., 2007). In more recent times
there has been an intense interest in identifying novel lymphoid
cell subsets which are thought to play an important role in bridg-
ing the gap between the innate and adaptive immune responses.
These subsets are largely segregated by their ability to rapidly
express effector cytokines more commonly associated with adap-
tive T helper cell responses such as IL-17 related cytokines or
IL-13 and IL-4. Perhaps unsurprisingly, this has led to signiﬁ-
cant advances in understanding the role of these subsets in both
autoimmune and allergic disease settings (Cai et al., 2011; Barlow
et al., 2012; Pantelyushin et al., 2012). However there is signiﬁcant
evidence to suggest that such subsets may also play a central role in
inﬂammation under sterile settings. In particular, the observation
that proinﬂammatory cytokines normally associated with adap-
tive T cell responses are elevated in certain auto-inﬂammatory
disease settings, in the absence of any identiﬁed sources of anti-
genic stimulation, indicates that iLCs may play an important role
(Lasiglie et al., 2011).
INNATE LYMPHOID CELL SUBSETS IMPLICATED
IN STERILE INFLAMMATION
γδ T CELLS
Arguably the most extensively described iLC populations are γδ
T cells, which comprise about 5% of the overall T cell population.
They differ fromconventionalαβTcells in that they express invari-
ant γ and δ chains as part of their T cell receptor and are resident
predominantly at mucosal sites (Cua and Tato, 2010). γδ T cells
appear to lack the requirement for conventional antigen presenta-
tion and this has contributed to the hypothesis that these cells act
as tissue-resident immune sentinel cells. Of particular relevance to
sterile inﬂammatory conditions are the recent observations from
both mouse and human studies that speciﬁc subsets of γδ T cells
respond to IL-R1 stimulation by expressing signiﬁcant levels of IL-
17A (Sutton et al., 2009; Ness-Schwickerath et al., 2010; Caccamo
et al., 2011). These cells which constitutively express CCR6 and the
transcription factor RORγT may act as an important instructive
signal to promote the generation of adaptive Th17 type responses
but have also been implicated as important mediators of disease
in their own right (Sutton et al., 2009). In particular, γδ T cells
which express IL-17A in response to IL-1α/β play an important
role in driving neutrophilia and dermal inﬂammation in psoria-
sis in both mouse models and human patients (Cai et al., 2011;
Laggner et al., 2011; Pantelyushin et al., 2012). Speciﬁcally, human
Vγ9Vδ2+ cells, which are induced to express IL-17A in the pres-
ence of IL-1β, have been implicated as playing a prominent role in
psoriasis (Laggner et al., 2011). As neutrophilic skin inﬂammation
is a prominent feature of cryopyrin-associated inﬂammatory syn-
drome (CAPS), which are autoinﬂammatory disorders, associated
with inﬂammasome hyperactivity and increased IL-1β processing,
it is tempting to speculate that Vγ9Vδ2+ T cells may play a role in
mediating these events (Kolivras et al., 2011). Indeed, in a recent
study, signiﬁcantly elevated levels of IL-17A was found in the
serumof CAPSpatients and althoughCD4+ Th17 cellswere impli-
cated as the source of IL-17A, the status of γδ T cell subsets was
not examined (Lasiglie et al., 2011). Similarly, characterizations
of Nlrp3 gene-targeted mice harboring mutations which mimic
those causing disease in humans have demonstrated signiﬁcant
skewing toward a Th17 type response. Of particular interest in this
regard, Meng et al. (2009) have demonstrated that mice express-
ing a R258W mutation (corresponding to the R260W mutation
found inMuckle–Wells disease patients) exhibit spontaneous skin
inﬂammation associated with neutrophil inﬂammation and a
Th17 dominated response. As this phenotype bears a remarkable
similarity to psoriasis, in which γδ T cells are a prominent source
of IL-17 related cytokines, it raises the possibility that γδ T cells
may also play an important role in skin manifestations among
CAPS patients.
While it has been established that caspase-1-dependent IL-
1β activity can promote expression of IL-17A by γδ T cells in
autoimmune disease settings (Lalor et al., 2011), whether this
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occurs under sterile settings has not been investigated. We have
found that the presence of IL-1β with IL-23 can induce signiﬁcant
rapid expression of IL-17A by murine γδ T cells in vivo under
sterile settings and in the absence of exogenous antigen. In con-
trast, CD3+ γδ TCR− cells do not express signiﬁcant levels of
IL-17A under these conditions (Figure 1). As both IL-1β and IL-
23 have been shown to be expressed at higher levels by monocyte
derived dendritic cells from CAPS patients (Lasiglie et al., 2011),
this further indicates that γδ T cell subsets may provide an impor-
tant innate source of IL-17 related cytokines in autoinﬂammatory
disease.
LYMPHOID TISSUE-INDUCER CELLS
Another prominent innate lymphoid subset characterized by their
ability to quickly and efﬁciently express IL-17 and/or IL-22 are
lymphoid tissue-inducer cells (LTi; Takatori et al., 2009). LTi cells
require the activity of the RORγT transcription factor for their
development and were initially identiﬁed for their role in driv-
ing lymphoid tissue development during embryogenesis. More
recently, LTi have been found to play important roles in innate
immune responses at mucosal surface such as the intestine and
the skin where they have been implicated as playing an important
role in responding to both pathogenic and commensal bacteria
(Ivanov et al., 2006; Pantelyushin et al., 2012). However there is
also emerging data indicating that these cells can play a prominent
role in sterile inﬂammatory settings.
As well as the autoinﬂammatory syndromes referred to above,
which result from genetic abnormalities, “sterile” inﬂammation
can also occur as a result of therapeutic regimens designed to
target speciﬁc cell populations for depletion. Treatments such as
chemotherapy and irradiation often result in undesirable effects
on the development of a healthy immune system with serious
consequences for the patient. Recently, it has been demonstrated
that LTi cells play a central role in promoting appropriate thymic
FIGURE 1 | IL-1β and IL-23 induce rapid expression of IL-17A by γδT cells
in vivo. C57Bl/6 mice were injected into the hind footpad with IL-1β (50 ng)
and IL-23 (50 ng) or PBS. After 4 h cells were harvested from the popliteal
lymph nodes and treated for a further 4 h with brefeldin A without ex vivo
stimulation. Cells were stained for expression of CD3, γδTCR and intracellular
IL-17A or isotype control and examined by ﬂow cytometry. (A) Data shown
as IL-17A expression by live CD3+γδTCR− and CD3+γδTCR+ cells is
representative of four separate experiments. (B)The percentage frequency
of CD3+γδTCR+ cells is unaltered after injection with IL-1β and IL-23. Data
representative of three individual mice.
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FIGURE 2 | Innate lymphoid subsets responding to sterile inflammation.
Innate lymphoid subsets such as γδT cells and LTi cells may respond to
increased IL-1β expression as a result of either genetic- or particulate-driven
inﬂammasome activation or IL-1α exposed upon tissue damage. These
DAMPs drive the innate expression of IL-17 family members which may
contribute to sterile inﬂammation or IL-22 which can promote tissue
regeneration. On the other hand, IL-33 exposed upon tissue damage,
drives type 2 innate responses by nuocytes and NH cells which can have
a proresolving inﬂuence and dampen sterile inﬂammatory responses
observed in obesity and atherosclerotic plaques.
regeneration in such sterile inﬂammatory settings (Dudakov et al.,
2012). These effects aremediated largely through expression of IL-
22 which promotes epithelial repair and tissue regeneration and
highlight the role of iLCs in promoting the resolution of “ster-
ile” inﬂammation (Dudakov et al., 2012). As an important source
of IL-17A at mucosal sites, LTi cells have also been found play an
important role in driving acute inﬂammatory responses to an array
of both infectious and chemical stimuli (Ivanov et al., 2006; Pante-
lyushin et al., 2012). Although whether these cells can speciﬁcally
respond to direct stimulation with DAMPs such as IL-1α/β (or
indeed IL-33) has yet to be fully investigated, it is possible that they
may also play an important role in bridging innate and adaptive
immunity under sterile settings.
INNATE TYPE-2 CELLS
The recent discovery of a number of subsets of innate immune
cells expressing ST-2 and responding to IL-33 has advanced our
understanding of this cytokine and further expanded its emerging
role as an alarmin (Liew et al., 2010). One such cell type, the
nuocyte, is an innate type 2 cell which was originally identiﬁed as
an IL-25 responsive non-T/non-B, γ-common chain-dependent
cell which provided IL-4, IL-5, and abundant amounts of IL-13 at
the onset of helminth infection (Neill et al., 2010). Interestingly,
nuocytes are also expanded upon treatment with IL-33 and cells
treated in this manner also secreted IL-6, IL-10, and GM-CSF
(Moro et al., 2010).
The ability of nuocytes to respond to IL-33 in this manner
implicates a role for these cells in the immune response to cel-
lular stress. It is established that tissue damage caused by factors
including high free fatty acids and oxidative stress commonly leads
to necrosis and release of IL-33 (Moussion et al., 2008; Cayrol
and Girard, 2009). Whilst no direct role for nuocytes has been
described under such conditions, it is tempting to speculate that
these cells could potentially provide an important source for at
least some of the cytokines expressed in these settings, including
IL-5, IL-10, and most notably IL-13 (Miller et al., 2010). For
example, in atherosclerotic lesions, where severe tissue damage
and necrosis are involved, IL-33 is thought to play a protective role
through its ability to switch what is a type 1 dominated response
toward a less inﬂammatory type 2 response. IL-33 increases the
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levels of IL-4, IL-5, and IL-13 and reduces incidence of F4/80
positive macrophages and CD3 positive cells found in atheroscle-
rotic lesions (Miller et al., 2008). These observations raise the
interesting possibility that nuocytes could potentially provide a
source of these cytokines and play a protective role in cardiac
disease.
The natural helper (NH) cell is another recent addition to the
expanding number of innate type 2 lymphoid cell populations
(Koyasu and Moro, 2011). These cells are capable of produc-
ing large amounts of IL-5 and IL-13 when stimulated by IL-33
in the presence of IL-2, IL-7, or thymic stromal lymphopoi-
etin (TSLP; Halim et al., 2012). Interestingly, and in contrast to
the other described innate type 2 populations, NH cells are pre-
dominantly found in fat-associated lymphoid clusters where it is
thought that they play important roles in maintenance of home-
ostasis in adipose tissues (Moro et al., 2010). Moreover, IL-33
and ST-2 expression in adipose tissue has been reported to play
a protective role in obesity-driven sterile inﬂammation through
promotion of a type 2 environment. These events were found to
occur in association with switching of the macrophage response
from a M1 to M2 phenotype raising the possibility that NH cells
could also contribute to the regulation of the sterile inﬂammatory
response to obesity by acting as an important orchestrator of the
type 2 response (Miller, 2011).
Nuocytes and NH cells are two phenotypically similar cell sub-
sets which respond to IL-33 and appear to play pathogenic roles
in models of allergic and parasitic inﬂammation. However with
the emerging importance of IL-33 as an endogenous danger signal
further investigation intowhat role these subsetsmay play inmedi-
ating type 2 immunity under some settings of sterile inﬂammation
could prove beneﬁcial.
CONCLUDING REMARKS
Although the innate immune response to DAMPs is critical to the
initiation of sterile inﬂammation, this often occurs in association
with enhanced expression of effector cytokines more commonly
associated with adaptive T helper cell responses. The recent identi-
ﬁcation of several iLC subsets which can respond rapidly to innate
stimuli by expressing such cytokines, in the absence of any obvious
requirement for antigenic stimulation, indicates that these subsets
may be important mediators of inﬂammation under sterile condi-
tions. Interestingly, the studies highlighted above, demonstrate
that these cells can play both proinﬂammatory and proresolv-
ing roles depending on the inﬂammatory setting and the effector
cytokines which are expressed (Figure 2). Further investigation
will likely reveal whether, as well as being critical regulators at
the interface between innate and adaptive immunity under set-
tings of infection and autoimmunity, these cells are also important
mediators of sterile inﬂammation.
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